Acosta EP - Search Results

1

Pharmacokinetic enhancers in HIV therapeutics.

Larson KB, Wang K, Delille C, Otofokun I, Acosta EP. Larson KB, et al. Among authors: acosta ep. Clin Pharmacokinet. 2014 Oct;53(10):865-72. doi: 10.1007/s40262-014-0167-9. Clin Pharmacokinet. 2014. PMID: 25164142 Review.

2

Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients.

Wang K, D'Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I. Wang K, et al. Among authors: acosta ep. Clin Pharmacokinet. 2014 Apr;53(4):361-71. doi: 10.1007/s40262-013-0122-1. Clin Pharmacokinet. 2014. PMID: 24311282 Free PMC article.

3

Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics.

Larson KB, King JR, Acosta EP. Larson KB, et al. Among authors: acosta ep. Adolesc Health Med Ther. 2013 Aug 27;4:79-87. doi: 10.2147/AHMT.S29462. eCollection 2013. Adolesc Health Med Ther. 2013. PMID: 24600298 Free PMC article. Review.

4

Helicase-primase as a target of new therapies for herpes simplex virus infections.

James SH, Larson KB, Acosta EP, Prichard MN. James SH, et al. Among authors: acosta ep. Clin Pharmacol Ther. 2015 Jan;97(1):66-78. doi: 10.1002/cpt.3. Epub 2014 Nov 18. Clin Pharmacol Ther. 2015. PMID: 25670384 Review.

5

Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy.

Xu F, Acosta EP, Liang L, He Y, Yang J, Kerstner-Wood C, Zheng Q, Huang J, Wang K. Xu F, et al. Among authors: acosta ep. Curr Drug Metab. 2017 Oct 16;18(8):769-781. doi: 10.2174/1389200218666170724112412. Curr Drug Metab. 2017. PMID: 28738768 Review.

6

Pharmacokinetic enhancement of protease inhibitor therapy.

King JR, Wynn H, Brundage R, Acosta EP. King JR, et al. Among authors: acosta ep. Clin Pharmacokinet. 2004;43(5):291-310. doi: 10.2165/00003088-200443050-00003. Clin Pharmacokinet. 2004. PMID: 15080763 Review.

7

Tipranavir: a novel nonpeptidic protease inhibitor of HIV.

King JR, Acosta EP. King JR, et al. Among authors: acosta ep. Clin Pharmacokinet. 2006;45(7):665-82. doi: 10.2165/00003088-200645070-00003. Clin Pharmacokinet. 2006. PMID: 16802849 Review.

8

Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.

Acosta EP, Grigsby PL, Larson KB, James AM, Long MC, Duffy LB, Waites KB, Novy MJ. Acosta EP, et al. J Infect Dis. 2014 Mar;209(6):898-904. doi: 10.1093/infdis/jit578. Epub 2013 Oct 31. J Infect Dis. 2014. PMID: 24179112 Free PMC article.

9

Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.

Delille CA, Pruett ST, Marconi VC, Lennox JL, Armstrong WS, Arrendale RF, Sheth AN, Easley KA, Acosta EP, Vunnava A, Ofotokun I. Delille CA, et al. Among authors: acosta ep. J Clin Pharmacol. 2014 Sep;54(9):1063-71. doi: 10.1002/jcph.298. Epub 2014 Apr 8. J Clin Pharmacol. 2014. PMID: 24691856 Free PMC article. Clinical Trial.

10

Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis.

Sutton AL, Acosta EP, Larson KB, Kerstner-Wood CD, Tita AT, Biggio JR. Sutton AL, et al. Among authors: acosta ep. Am J Obstet Gynecol. 2015 Jun;212(6):812.e1-6. doi: 10.1016/j.ajog.2015.01.015. Epub 2015 Jan 13. Am J Obstet Gynecol. 2015. PMID: 25595580 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page